School of Life Science and Technology Shandong Second Medical University, Weifang 261021, China.
Department of Pediatric Surgery Weifang People's Hospital The First Affiliated Hospital of Shandong Second Medical University, Weifang 261021, China.
J Diabetes Res. 2024 Sep 4;2024:5544296. doi: 10.1155/2024/5544296. eCollection 2024.
The aim of the study is to identify the regulatory role of intestinal sweet taste receptors (STRs) and glucose transporters (SGLT1, GLUT2) and gut peptide secretion in duodenal-jejunal bypass (DJB)-ameliorated glycemic control in Type 2 diabetes. DJB and sham surgeries were performed in streptozotocin-induced diabetic male rats. The blood GLP-1 and GLP-2 levels were evaluated under feeding and fasting conditions. The expression of STRs (T1R2, T1R3), sweet taste signaling effector (G-gustducin), SGLT1, and GLUT2 was detected in the intestinal alimentary limb (A limb), biliopancreatic limb (BP limb), and common limb (C limb). The effects of STR inhibition on glucose control were measured with lactisole. Glucose tolerance was improved in DJB-operated rats compared with the sham group, similar to that of normal control rats, without significant differences in food intake and body weight. The plasma GLP-1 levels of DJB rats were increased under diet-fed condition, and GLP-2 levels were increased after fasting. The villus height and crypt depth were significantly increased in the A limb of DJB-operated rats. In addition, GLP-1 expression was restored in enterocytes. The expression of T1R2, G-gustducin, and SGLT1 was elevated in the A limb after DJB, while GLUT2 was downregulated in the A, BP, and C limbs. The localization of GLUT2 was normalized in the three intestinal limbs after DJB. However, the beneficial effects of DJB on glucose control were abolished in the presence of lactisole in vivo. DJB ameliorates glycemic control probably by restoring STR-mediated glucose sensing and absorption with the responses of GLP-1 and GLP-2 to carbohydrate.
本研究旨在确定肠道甜味受体(STRs)和葡萄糖转运蛋白(SGLT1、GLUT2)的调节作用以及肠道肽分泌在十二指肠-空肠旁路(DJB)改善 2 型糖尿病患者血糖控制中的作用。在链脲佐菌素诱导的糖尿病雄性大鼠中进行 DJB 和假手术。在进食和禁食条件下评估血液 GLP-1 和 GLP-2 水平。在肠营养支(A 支)、胆胰支(BP 支)和共同支(C 支)中检测 STRs(T1R2、T1R3)、甜味信号效应物(G- gustducin)、SGLT1 和 GLUT2 的表达。用乳果糖抑制 STR 对葡萄糖控制的影响。与假手术组相比,DJB 手术大鼠的葡萄糖耐量得到改善,与正常对照组大鼠相似,摄食量和体重无显著差异。DJB 大鼠在饮食喂养条件下的血浆 GLP-1 水平增加,禁食后 GLP-2 水平增加。DJB 手术大鼠 A 支的绒毛高度和隐窝深度显著增加。此外,肠细胞中的 GLP-1 表达得到恢复。DJB 后 A 支中 T1R2、G- gustducin 和 SGLT1 的表达升高,而 A、BP 和 C 支中的 GLUT2 下调。DJB 后 GLUT2 在三个肠支中的定位得到了正常化。然而,体内存在乳果糖时,DJB 对葡萄糖控制的有益作用被消除。DJB 可能通过恢复 STR 介导的葡萄糖感知和吸收,以及对碳水化合物的 GLP-1 和 GLP-2 反应来改善血糖控制。